| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2007 | WO2006052886A8 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| 06/14/2007 | WO2006048768A8 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 06/14/2007 | WO2006041769A3 Methods for the treatment of substance abuse and addiction |
| 06/14/2007 | WO2006039418A3 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 06/14/2007 | WO2006028635A3 Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis |
| 06/14/2007 | WO2006007558A3 Novel compositions and methods in cancer |
| 06/14/2007 | WO2005107738A3 Basic amino acid-methionine hydroxy analog compositions |
| 06/14/2007 | WO2005099367A3 Systems and methods for improving image-guided tissue ablation |
| 06/14/2007 | WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/14/2007 | WO2005038042A3 Systems and methods for assessing neuronal degeneration |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135636 Use of cyclic bioisosters of purine system derivatives for treating diseases produced by disorders of niterergic and dopaminergic systems |
| 06/14/2007 | US20070135526 Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof |
| 06/14/2007 | US20070135525 Materials and methods for treating viral infections |
| 06/14/2007 | US20070135524 Process for the preparation of polymorphs of selective serotonin reuptake inhibitor |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135522 acupuncture pain relief with electrical current to needle electrodes stuck into sensitive points; intravenous infusion of a substance that inhibits enzymatic decomposition of endogenous opioid neuropeptides, (enkephalins and endorphins); e.g. D-phenylalanine and D-leucine |
| 06/14/2007 | US20070135521 Agent for Preventing Metabolic Syndrome |
| 06/14/2007 | US20070135520 Cis-trans isomerisation of semicarbazone compounds |
| 06/14/2007 | US20070135519 For reducing, preventing, mitigating, and/or delaying the onset of, attenuating the severity of, and/or hastening the resolution of, chemotherapy-associated toxicities; nucleosides |
| 06/14/2007 | US20070135518 Use of low-dose ladostigil for neuroprotection |
| 06/14/2007 | US20070135517 Antitumor medicine |
| 06/14/2007 | US20070135516 irciniastatins, essentially pure, isolated from Indo-Pacific marine sponge Ircinia ramosa by cancer cell line bioassay-guided techniques; isochromene-pyran derivatives; dichloromethane-methanol extract; anticarcinogenic agent; P388 lymphocytic leukemia and pancreas, breast, CNS, lung cancer cell lines |
| 06/14/2007 | US20070135515 Method for producing sorbicillactone a |
| 06/14/2007 | US20070135514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/14/2007 | US20070135513 Method for producing {n-[1-(s)-carbalkoxy-3-phenylpropyl]-s-alanyl-2s, 3ar, 7as-octahydroindole-2-carboxylic acid} compounds |
| 06/14/2007 | US20070135512 Novel crystalline forms of perindopril erbumine |
| 06/14/2007 | US20070135511 nonsteroidal progestagens; selectivity; 6-Chloro-5-fluoro-2-phenyl-3-phenylsulfanyl-1H-indole; contraceptives; amenorrhea, dysfuntional bleeding; polycysticovarian syndrome, anticancer, side effect reduction of cyclid menstrual bleeding, food intake stimulation |
| 06/14/2007 | US20070135510 Analgesics; Alzheimer's disease or Parkinson's disease; attention deficit disorder; schizophrenia; vascular dementia; 3-[(2-METHOXYPHENYL)IMINO]-1-PHENYL-1,3-DIHYDRO-2H-INDOL-2-ONE |
| 06/14/2007 | US20070135509 Indolone compounds useful to treat cognitive impairment |
| 06/14/2007 | US20070135508 e.g. (2(2S)-(1 alpha , 5 alpha , 6 alpha )-6-N-[3-benzyl-3-azabicyclo[3.1.0]-hexyl]-2-[(1R or 1S)-3-oxocyclohexyl]-2-hydroxy-2-phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent |
| 06/14/2007 | US20070135507 N-1-[(4-chlorophenyl)]-N-2-{[4-(2{dimethylaminomethyl }phenyl)phenyl]-}-(2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxamide; inhibitors of coagulation factor Xa; thromboembolic diseases; tumors |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135504 Combination therpay; antibiotics such as 30S or 50S ribosomal subunit inhibitors, with e.g. Angiotensin Receptor Blockers (ARB) such as olmesartan; inflammatory diseases, including autoimmune and neurological diseases; Vitamin D receptor (VDR); CB1, Cannabinoid Receptor 1; Glucocorticoid Receptor (GCR) |
| 06/14/2007 | US20070135503 [(Alkyl-phenyl-furan-3-carbonyl)-amino]-phenyl-acetic acids; for treatment of headaches and migraines |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135501 Amino acid derivatives |
| 06/14/2007 | US20070135500 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | US20070135499 Hydrazide compounds |
| 06/14/2007 | US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers |
| 06/14/2007 | US20070135496 Substituted benzylaminoalkylene heterocycles |
| 06/14/2007 | US20070135495 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarboxylate gentisate; crystalline acid salt; low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood; cardiovascular diseases, hypotensive agent |
| 06/14/2007 | US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides |
| 06/14/2007 | US20070135493 Inhibitors of ion channels |
| 06/14/2007 | US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin |
| 06/14/2007 | US20070135490 Phenetanolamine derivatives |
| 06/14/2007 | US20070135489 Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones |
| 06/14/2007 | US20070135488 Amlodipine nicotinate and process for the preparation thereof |
| 06/14/2007 | US20070135487 containing N-(5-adamantane-1-yl-methoxy-pentyl)- group; for treatment of insulin resistance, hyperpigmentation and/or inflammatory processes in skin, fungal disease, overweight and obesity, or microbacterial infection |
| 06/14/2007 | US20070135486 antidiabetic drugs or foods; sulfonium compounds |
| 06/14/2007 | US20070135485 Novel mch receptor antagonists |
| 06/14/2007 | US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 06/14/2007 | US20070135483 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 06/14/2007 | US20070135482 Substituted pyrrolidine and related compounds |
| 06/14/2007 | US20070135481 Compositions and methods of treating retinal disease |
| 06/14/2007 | US20070135480 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 06/14/2007 | US20070135479 Isoquinoline derivatives |
| 06/14/2007 | US20070135478 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 06/14/2007 | US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/14/2007 | US20070135476 Process for producing thiazole derivative |
| 06/14/2007 | US20070135475 Process for the preparation of ccr-2 antagonists |
| 06/14/2007 | US20070135474 ((1R,3S)-3-Isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl} cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine succinate as a crystalline solid; potent chemokine receptor inhibitor |
| 06/14/2007 | US20070135473 retarding the metastasis of an epithelial or mesenchymal tumor which expresses S100 human calcium binding protein comprising administering 2-amino-7-isopropyl-1-azaxanthone-3-carboxylic acid or salts |
| 06/14/2007 | US20070135472 Novel crystalline forms of desloratadine and processes for their preparation |
| 06/14/2007 | US20070135471 Reacting 1-chlorocarbonyl-4-piperidinopiperidine hydrochloride and 7-ethyl-10-hydroxycamptothecin in polar aprotic solvent with diisopropylethylamine in presence of catalytic amount of N-containing cyclic organic compound, and optionally in the presence of a water binding agent |
| 06/14/2007 | US20070135470 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
| 06/14/2007 | US20070135469 Vinylsulfonate and vinylsulfonamide compounds |
| 06/14/2007 | US20070135467 Heterocyclic cetp inhibitors |
| 06/14/2007 | US20070135466 Pyrrolopyridines useful as inhibitors of protein kinase |
| 06/14/2007 | US20070135465 Fab I Inhibitor and Process for Preparing Same |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135463 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing same |
| 06/14/2007 | US20070135462 AZD2171 or salts except the maleate salt with a taxane; AZD2171 is 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline, aka cediranib |
| 06/14/2007 | US20070135461 3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; immune-related diseases, skin disorders, myeloid proliferative disorders, cancer |
| 06/14/2007 | US20070135460 7H-pyrrolopyrimidine derivatives |
| 06/14/2007 | US20070135459 Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors |
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |
| 06/14/2007 | US20070135457 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde2 inhibitors |
| 06/14/2007 | US20070135456 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione: hyperlipoproteinaemia, dyslipidaemia, heart failure, hypercholesteraemia, atherosclerosis, arteriosclerosis, and hypertriglyceridaemia |
| 06/14/2007 | US20070135455 inhibitors Tie2 receptor tyrosine kinase; N-{3-[5-(4-aminothieno[2,3-d]pyrimidin-6-yl)-1-methyl-1H-imidazol-4-yl]phenyl}-N'-(3-fluorophenyl)urea; antiangiogenic effect; cancer, rheumatoid arthritis |
| 06/14/2007 | US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) |
| 06/14/2007 | US20070135452 Nitrogen-containing fused heterocyclic compounds |
| 06/14/2007 | US20070135451 Imidazo[1,2-a]Pyridine Derivatives for Treatment Of Herpes Viral Infections |
| 06/14/2007 | US20070135450 Compounds and Methods of Treating Insulin Resistance and Cardiomyopathy |
| 06/14/2007 | US20070135449 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| 06/14/2007 | US20070135448 Use of cathepsin k inhibitors for treating of severe bone loss diseases |
| 06/14/2007 | US20070135447 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 06/14/2007 | US20070135446 Benzoylguanidlne salt and hydrates thereof |
| 06/14/2007 | US20070135445 Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents |
| 06/14/2007 | US20070135444 Treatment of neuroblastoma |
| 06/14/2007 | US20070135443 Novel tyrosine kinase inhibitors |
| 06/14/2007 | US20070135442 Chroman compounds |
| 06/14/2007 | US20070135441 e.g. 6-[4-({4-[(5-chloro-1H-indol-2-yl)sulphonyl]piperazin-1-yl}carbonyl)phenyl]-2-[2-(dimethylamino)ethyl]pyridazin-3(2H)-one; anticoagulant; protease, blood coagulation factor Xa inhibitor; thrombosis, atherosclerotic plaques, restenosis, bypass surgery, cerebral infarction, ischemia and angina |
| 06/14/2007 | US20070135440 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 06/14/2007 | US20070135439 Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/14/2007 | US20070135438 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | US20070135437 Modulation of neurodegenerative diseases |
| 06/14/2007 | US20070135436 Chemical compounds |
| 06/14/2007 | US20070135435 Certain chemical entities, compositions, and methods |